Press Releases

• Arrowhead Pharmaceuticals: Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia More
• Cedars-Sinai: Scientists Track Body's Most Elusive Proteins More
• Cloudbreak Pharma: Successful End-of-Phase-2 Meeting and Alignment With FDA on Phase 3 Path Forward for CBT-004 More
• Lunai Bioworks: Expands NIH-Funded AI Program Into Commercial Alcohol Use Disorder Drug Discovery More
• LuskinOIC: Establishes New Research Award Honoring Pioneering Scientist Dr. Harry A. McKellop More
• START: Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site More
• StemCyte: FDA Clearance of Expanded Access Program for RegeneCyte (HPC, Cord Blood) to Address Unmet Need in Long COVID More

Financial News

• 4DMedical: Secures US$100+ Million Funding to Accelerate U.S. Expansion and Increase Technology Dominance in Software-Based Lung Imaging More
  
• More on Arcutis, Kowa Parting Ways on US Marketing Partnership for Zoryve More
  
• New Rules, Higher Stakes: Biopharma Plays the Long Game in 2026 More
  
• Get Full Access to BYTE51 Life Sciences Intelligence for 50% Off More

Media/Misc Coverage

• Subscribe to LifeSci Startup for Updates on US Startups More
• The Big4Bio Podcast: Every Moment Matters: Getting Better Insights on Target and off Target Biology Mark Aspinall and Jim Raymond Podcast
• UCLA Health: Researchers Discover a Previously Unknown Bacterial Component in Kidney Stone Formation More More

Companies

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
  
• BioSpace Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs More
  
• Former FDA Deputies Land at Lilly, AbbVie; Italy’s Angelini Has a New CEO More*
  
• From Seed to Series C: What Investors Look for Beyond the Science More
• 11 Companies Hiring Manufacturing Professionals Now More
• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
  
• ICYMI: The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• ICYMI: CEO's Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO's Perspective: The High Cost of Job Hopping More
• 12 Companies Hiring R&D Professionals Now More

• PepTalk 2026 Jan 19-27
• SLAS2026 International Conference & Exhibition Feb 7-12
• IO360° Summit Feb 10-12
• Biocom California’s Global Partnering & Investor Conference Feb 24-26
• PMWC March 4-6
• Rare Disease Summit March 17-19

Los Angeles Sponsors